State of Alaska Department of Revenue’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.13M Buy
56,215
+4,546
+9% +$334K 0.04% 404
2025
Q1
$5.9M Sell
51,669
-1,327
-3% -$152K 0.07% 269
2024
Q4
$2.67M Sell
52,996
-49
-0.1% -$2.47K 0.03% 546
2024
Q3
$2.45M Sell
53,045
-746
-1% -$34.5K 0.03% 644
2024
Q2
$1.75M Sell
53,791
-1,469
-3% -$47.7K 0.02% 727
2024
Q1
$1.39M Sell
55,260
-257
-0.5% -$6.47K 0.02% 860
2023
Q4
$1.8M Sell
55,517
-669
-1% -$21.7K 0.02% 732
2023
Q3
$1.53M Sell
56,186
-3,298
-6% -$89.8K 0.02% 745
2023
Q2
$1.32M Sell
59,484
-6,124
-9% -$136K 0.02% 831
2023
Q1
$1.42M Sell
65,608
-1,006
-2% -$21.8K 0.02% 809
2022
Q4
$1.35M Buy
66,614
+619
+0.9% +$12.6K 0.02% 809
2022
Q3
$1.69M Sell
65,995
-6,289
-9% -$161K 0.02% 684
2022
Q2
$1.72M Buy
72,284
+5,775
+9% +$137K 0.02% 713
2022
Q1
$1.5M Sell
66,509
-690
-1% -$15.5K 0.02% 775
2021
Q4
$1.33M Sell
67,199
-8,910
-12% -$176K 0.01% 918
2021
Q3
$1.5M Buy
76,109
+3,468
+5% +$68.2K 0.02% 856
2021
Q2
$1.6M Buy
72,641
+1,170
+2% +$25.7K 0.02% 827
2021
Q1
$1.7M Sell
71,471
-9,910
-12% -$236K 0.02% 748
2020
Q4
$2.13M Sell
81,381
-15,925
-16% -$416K 0.02% 586
2020
Q3
$1.69M Buy
97,306
+10
+0% +$174 0.02% 631
2020
Q2
$1.64M Buy
97,296
+6,090
+7% +$102K 0.02% 650
2020
Q1
$1.08M Buy
91,206
+13,540
+17% +$161K 0.02% 727
2019
Q4
$939K Sell
77,666
-938
-1% -$11.3K 0.01% 945
2019
Q3
$1.11M Buy
78,604
+43,024
+121% +$608K 0.02% 804
2019
Q2
$396K Buy
35,580
+393
+1% +$4.37K 0.01% 1185
2019
Q1
$413K Buy
35,187
+50
+0.1% +$587 0.01% 1157
2018
Q4
$469K Buy
35,137
+943
+3% +$12.6K 0.01% 999
2018
Q3
$479K Buy
34,194
+2,924
+9% +$41K 0.01% 1132
2018
Q2
$491K Buy
31,270
+510
+2% +$8.01K 0.01% 1079
2018
Q1
$506K Buy
30,760
+13,020
+73% +$214K 0.01% 947
2017
Q4
$320K Buy
+17,740
New +$320K 0.01% 1010